Novo Nordisk
NVO
NVO
1,852 hedge funds and large institutions have $47.9B invested in Novo Nordisk in 2024 Q2 according to their latest regulatory filings, with 215 funds opening new positions, 759 increasing their positions, 583 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 1,737 → 1,852 (+115)
0.43% more ownership
Funds ownership: 9.46% → 9.9% (+0.43%)
4% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.13B
Holders
1,852
Holding in Top 10
90
Calls
$1.09B
Puts
$1.13B
Top Buyers
| 1 | +$371M | |
| 2 | +$272M | |
| 3 | +$270M | |
| 4 |
Millennium Management
New York
|
+$264M |
| 5 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$227M |
Top Sellers
| 1 | -$231M | |
| 2 | -$128M | |
| 3 | -$120M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$107M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$104M |